Osteoarthritis (OA) is the most common disease of joints, affecting over 300 million people. It is characterised by joint pain and stiffness, leading to joint dysfunction over time. This paper presents current recommendations for the use of imaging (published by EULAR) and management of OA (issued by EULAR, ACR and NICE). The goal of the treatment is to control symptoms of the disease, maintain joint function and maximise patient’s performance
Osteoarthritis (OA) is a chronic degenerative joint disease of dynamic pathology with multiple etiol...
IntroductionThe National Institute for Health and Care Excellence (NICE) suggest there is no role fo...
Osteoarthritis (OA) is the most common musculoskeletal disease leading to functional decline and los...
Osteoarthritis (OA) is the most common disease of joints, affecting over 300 million people. It is c...
The increased information provided by modern imaging has led to its more extensive use. Our aim was ...
Osteoarthritis (OA) is a degenerative disease that causes pain, limitation of movement, and disabili...
SummaryImaging of hip in osteoarthritis (OA) has seen considerable progress in the past decade, with...
Osteoarthritis (OA) is the most prevalent joint disorder in the elderly, and there is no effective t...
PURPOSE: As a prelude to developing updated, evidence-based, international consensus recommendations...
SummaryPurposeAs a prelude to developing updated, evidence-based, international consensus recommenda...
Background: Recent innovations in the pharmaceutical drug discovery environment have generated new c...
Introduction: The National Institute for Health and Care Excellence (NICE) suggest there is no role ...
SummaryObjectiveThe European Society on Clinical and Economic aspects of Osteoporosis and Osteoarthr...
Background: Osteoarthritis, characterised by joint pain and stiffness, is a common and significant c...
Osteoarthritis (OA) is a chronic, debilitating disease affecting millions of people worldwide. Manag...
Osteoarthritis (OA) is a chronic degenerative joint disease of dynamic pathology with multiple etiol...
IntroductionThe National Institute for Health and Care Excellence (NICE) suggest there is no role fo...
Osteoarthritis (OA) is the most common musculoskeletal disease leading to functional decline and los...
Osteoarthritis (OA) is the most common disease of joints, affecting over 300 million people. It is c...
The increased information provided by modern imaging has led to its more extensive use. Our aim was ...
Osteoarthritis (OA) is a degenerative disease that causes pain, limitation of movement, and disabili...
SummaryImaging of hip in osteoarthritis (OA) has seen considerable progress in the past decade, with...
Osteoarthritis (OA) is the most prevalent joint disorder in the elderly, and there is no effective t...
PURPOSE: As a prelude to developing updated, evidence-based, international consensus recommendations...
SummaryPurposeAs a prelude to developing updated, evidence-based, international consensus recommenda...
Background: Recent innovations in the pharmaceutical drug discovery environment have generated new c...
Introduction: The National Institute for Health and Care Excellence (NICE) suggest there is no role ...
SummaryObjectiveThe European Society on Clinical and Economic aspects of Osteoporosis and Osteoarthr...
Background: Osteoarthritis, characterised by joint pain and stiffness, is a common and significant c...
Osteoarthritis (OA) is a chronic, debilitating disease affecting millions of people worldwide. Manag...
Osteoarthritis (OA) is a chronic degenerative joint disease of dynamic pathology with multiple etiol...
IntroductionThe National Institute for Health and Care Excellence (NICE) suggest there is no role fo...
Osteoarthritis (OA) is the most common musculoskeletal disease leading to functional decline and los...